---
title: "CRIS Connect: Accelerating Clinical Innovations into Market"
permalink: /cris-connect-accelerating-clinical-innovations-into-market/
date: 2025-07-07
layout: post
description: ""
image: ""
variant: tiptap
---
<p></p>
<div class="isomer-image-wrapper">
<img style="width: 100%" height="auto" width="100%" alt="" src="/images/Resources_Events/2025/CRIS_Connect_Jul_2025_FA.jpg">
</div>
<p><strong>Registration</strong>
</p>
<p><strong>Please register via</strong>  <strong><a rel="noopener noreferrer nofollow" target="_blank">https://for.sg/crisconnect<br>Registration</a></strong> closes
Mon, 28 Jul 2025.</p>
<hr>
<p><strong>About the Speakers</strong>
</p>
<p><strong>Dr Aishwarya Bandla</strong>
<br><em>Clinical Innovation Manager, Paxman Coolers Ltd</em>
</p>
<p>Dr Aishwarya Bandla holds a Ph.D. in Biomedical Engineering from the National
University of Singapore (NUS). Her research specialises in wearable technology
for cancer care. At Paxman Coolers Ltd., she leads the development of a
wearable limb cryocompression device to prevent chemotherapy-induced peripheral
neuropathy.</p>
<p>She also serves as an Adjunct Senior Research Fellow and Principal Investigator
at the N.1 Institute for Health, NUS as well as the Vice Chair of the Insitute
of Electrical and Electronics Engineers (IEEE) Singapore Section.</p>
<p>Dr Bandla is a recipient of multiple awards, including Outstanding Mentor
by the Singapore Medical Association Charity Fund and named Singapore's
100 Women in Tech in 2020.</p>
<p><strong>Dr Rachel Wong Su Jen</strong>
<br><em>Consultant (Medical Oncology), National University Cancer Institute, Singapore (NCIS), National University Health System (NUHS)</em>
</p>
<p>Dr Rachel Wong Su Jen is a Medical Oncology Consultant at NCIS. Her clinical
and research interest is in breast cancer, with a special focus on cancer
supportive care and the use of digital health to improve patient care and
healthcare delivery.</p>
<p>She is the Primary Investigator of the clinical trial evaluating the use
of a wearable limb cryocompression device to prevent chemotherapy-induced
peripheral neuropathy.</p>
<p>Dr Wong is also a member of the Haematology-Oncology Research Group, a
cancer clinical trials unit that conducts phase I to III therapeutics clinical
trials in solid tumours and haematological maligancies at NCIS.</p>
<p><strong>Ms Smitha Velayil</strong>
</p>
<p><em>Manager (Innovation &amp; Enterprise), National Health Innovation Centre Singapore (NHIC), Consortium for Clinical Research and Innovation, Singapore (CRIS)</em>
</p>
<p>Ms Smitha Velayil holds a dual Masters degree in Biotechnology and Business
Administration (MSc-MBA).&nbsp;In her current role at NHIC, she manages
biomedical technology projects from the public healthcare institutes towards
commercialisation.</p>
<p>She also manages the community and international partnership activities
at NHIC. She started her career as a clinical research coordinator in the
field of infectious diseases before moving on to roles in business development
and programme management.</p>
<p>In these roles, Ms Smitha worked closely with government agencies to develop
interdisciplinary big data projects and strategic partnerships within the
biomedical cluster and clinical community.</p>
<p>&nbsp;</p>